Filing Flows › Artivion (AORT) › Q3 2025
Artivion (AORT) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 7, 2025
Artivion (AORT) reported revenue of $113M for the third quarter 2025 (Q3 2025), +18% from a year earlier and +0.4% from the quarter before. Operating margin was 11.1%, net earnings $6.5M (5.7% of revenue).
Artivion, Q3 2025: revenue $113M (+18% year over year), operating margin 11.1%, net earnings $6.5M, operating cash flow $22.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $113M | +0.4% | +18% |
| Gross profit | $74.4M | +2% | +22% |
| Operating profit | $12.5M | +50% | +186% |
| Net earnings | $6.5M | +383% | — |
| Operating cash flow | $22.3M | +48% | +94% |
| Free cash flow | $17.7M | +51% | +126% |
What changed
Revenue was $113.4M in Q3 2025, up 18% year over year and roughly flat from the previous quarter. Aortic stent grafts was the largest line at 35% of revenue. Aortic stent grafts added $10.9M year over year (up 38%), 62% of the total change. Other declined 11%.
Gross margin was 65.6%, up 1.9 points from a year earlier. Operating profit was $12.5M, a 11.1% margin (up 6.5 points year over year). Of the extra revenue versus a year earlier, 46% reached operating profit, above the 5% margin then. Operating expenses grew 9% against revenue growth of 18%. Net earnings were $6.5M. The effective tax rate was 7.9%.
Operating cash flow was $22.3M (up 94% year over year), 342% of net earnings. Non-cash charges added back $5.7M of depreciation and amortization and $6.1M of share-based compensation. Working capital and other items added $3.9M. Capital expenditures of $4.6M left free cash flow of $17.7M.
Questions
What was Artivion's revenue in the third quarter 2025?
Artivion (AORT) reported revenue of $113M for the third quarter 2025 (Q3 2025), +18% from a year earlier and +0.4% from the quarter before.
Was Artivion profitable in the third quarter 2025?
Operating profit was $12.5M (11.1% of revenue) and net earnings $6.5M.
Source: Artivion 10-Q on SEC EDGAR.